Correlation Between Freedom Bank and Eupraxia Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Freedom Bank and Eupraxia Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Freedom Bank and Eupraxia Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Freedom Bank of and Eupraxia Pharmaceuticals Common, you can compare the effects of market volatilities on Freedom Bank and Eupraxia Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Freedom Bank with a short position of Eupraxia Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Freedom Bank and Eupraxia Pharmaceuticals.
Diversification Opportunities for Freedom Bank and Eupraxia Pharmaceuticals
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Freedom and Eupraxia is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Freedom Bank of and Eupraxia Pharmaceuticals Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eupraxia Pharmaceuticals and Freedom Bank is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Freedom Bank of are associated (or correlated) with Eupraxia Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eupraxia Pharmaceuticals has no effect on the direction of Freedom Bank i.e., Freedom Bank and Eupraxia Pharmaceuticals go up and down completely randomly.
Pair Corralation between Freedom Bank and Eupraxia Pharmaceuticals
Given the investment horizon of 90 days Freedom Bank is expected to generate 5.32 times less return on investment than Eupraxia Pharmaceuticals. But when comparing it to its historical volatility, Freedom Bank of is 4.79 times less risky than Eupraxia Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Eupraxia Pharmaceuticals Common is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 250.00 in Eupraxia Pharmaceuticals Common on October 4, 2024 and sell it today you would earn a total of 67.00 from holding Eupraxia Pharmaceuticals Common or generate 26.8% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Freedom Bank of vs. Eupraxia Pharmaceuticals Commo
Performance |
Timeline |
Freedom Bank |
Eupraxia Pharmaceuticals |
Freedom Bank and Eupraxia Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Freedom Bank and Eupraxia Pharmaceuticals
The main advantage of trading using opposite Freedom Bank and Eupraxia Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Freedom Bank position performs unexpectedly, Eupraxia Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will offset losses from the drop in Eupraxia Pharmaceuticals' long position.Freedom Bank vs. National Capital Bank | Freedom Bank vs. Community Heritage Financial | Freedom Bank vs. Citizens Financial Corp | Freedom Bank vs. Bank of Idaho |
Eupraxia Pharmaceuticals vs. Vaccinex | Eupraxia Pharmaceuticals vs. Dogwood Therapeutics, | Eupraxia Pharmaceuticals vs. enGene Holdings Common | Eupraxia Pharmaceuticals vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |